The pharmaceutical stability and storage services market is estimated to witness high growth owing to increasing complexity in drug development. Pharmaceutical stability and storage services help ensure the safety and efficacy of drugs by conducting various tests to determine stability and degradation quality of drugs throughout their shelf life. These services play a crucial role in drug development and commercialization by providing analytical support and stability testing as per the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines.

The Global pharmaceutical stability and storage services market is estimated to be valued at US$ 3.18 Bn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the pharmaceutical stability and storage services are Intertek Group plc, Eurofins Scientific, SGS Société Générale de Surveillance SA., Q Laboratories, BioLife Solutions Inc., Cencora, Inc., Alloga, PCI Pharma Services, Pharmaserv GmbH, Catalent, Inc, Almac Group, Charles River Laboratories, Lucideon, Alcami Corporation, Element Materials Technology, Nelson Laboratories, LLC, ALS.

Pharmaceutical Stability And Storage Services Market Trends and rising demand for biosimilars and biologics testing. Pharmaceutical companies are increasingly outsourcing stability testing to CROs to minimize costs and focus on core activities.

Globally, the market is expected to witness high growth in the Asia Pacific region owing to increasing investment by global players and rising generics market. Countries like China, India, Japan and South Korea are expected to offer lucrative growth opportunities during the forecast period.

Get More Insights On, Pharmaceutical Stability and Storage Services Market